Statement for the Record: FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics February 3, 2022, 10:30 a.m. United States House Committee on Energy and CommerceRandall L. RuttaChief […]
Letters + Comments
NHC Comments on HHS Notice of Benefit and Payment Parameters for 2023
NHC 2023 NBPP Comments on Letterhead January 27, 2022 Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services 7500 Security Blvd Baltimore, MD 212441 […]
Letter of Support for Dr. Robert Califf FDA Commissioner Nominee
Califf Nomination Letter Final (PDF) December 13, 2021 The Honorable Patty Murray Chair Committee on Health, Education, Labor, and Pensions United States Senate 154 Russell Office Building Washington, DC 20510 […]
NHC Comments on FDA-2020-D-2316 for Benefit-Risk Assessment for New Drug and Biological Products; Draft Guidance for Industry
Food and Drug Administration Dockets Management Staff (HFA-305) 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 RE: FDA-2020-D-2316 for “Benefit-Risk Assessment for New Drug and Biological Products; Draft Guidance for […]
NHC RWE, EHR and Medical Claims Comments
Dockets Management Staff Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane, Rm.1061 Rockville, MD 20852 RE: FDA Guidance, “Real-World Data: Assessing Electronic Health Records and […]
NHC Comments on PDUFA Reauthorization Performance Goals and Procedures FY 2023-2027
PDF Version October 28, 2021 Janet Woodcock, MD Acting Commissioner US Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 RE: PDUFA Reauthorization Performance Goals and Procedures […]
CMS Physician Fee Schedule Proposed Rule
The National Health Council (NHC) appreciates the opportunity to provide comments on the above-referenced Proposed Rule [the Physician Fee Schedule (PFS)], particularly on issues of access to telehealth services for […]
Recommendations to Congress for Reconciliation Legislation
Dear Leader Schumer, Minority Leader McConnell, Speaker Pelosi, and Minority Leader McCarthy: On behalf of the National Health Council (NHC), I am writing to share our recommendations for policies to […]
Patient-Centered Outcomes Research Institute (PCORI) National Health Priorities
On behalf of the National Health Council (NHC), I am pleased to offer the following comments on the proposed national priorities for health. We appreciate our long partnership with the […]
Cures 2.0 Discussion Draft
The National Health Council (NHC) is pleased to respond to the discussion draft of 21st Century Cures 2.0 legislation. Created by and for patient organizations 100 years ago, the NHC […]